Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMITRIPTYLINE vs AMLODIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMITRIPTYLINE vs AMLODIPINE: Safety Overview

Metric AMITRIPTYLINE AMLODIPINE
Total FAERS Reports 20,382 64,924
Deaths Reported 4,837 10,161
Death Rate 23.7% 15.7%
Hospitalizations 7,290 26,787
Average Patient Age 55.2 yrs 62.8 yrs
% Female Patients 70.9% 57.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 12, 2011
Manufacturer Proficient Rx LP Teva Pharmaceuticals USA, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription